This research compound contains GLP/GIP (Glucagon-Like Peptide / Glucose-Dependent Insulinotropic Polypeptide) in a 30 mg formulation, studied for its role in enhancing insulin secretion, regulating blood glucose, influencing appetite control, and supporting metabolic pathways.
$1,000.00
GLP/GIP (Glucagon-Like Peptide / Glucose-Dependent Insulinotropic Polypeptide) 30 mg is a dual incretin peptide analogue studied for its effects on glucose metabolism, insulin secretion, appetite regulation, and weight management.
Applications:
• Research on dual incretin mechanisms and metabolic pathways
• Studies of insulin secretion, glucose control, and energy balance
• Experimental models of appetite suppression and weight regulation
Important Notice:
It is supplied as a lyophilized powder for reconstitution and is intended for non-human research purposes only.
